Author

Richard A. Friedman

Primary ORCID profile (0000-0002-5136-2998 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Richard A. FriedmaniD2 papers · Columbia University Irving Medical Center

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Christine E. SeidmaniD· 1 shared Daniel N. Tavakol· 1 shared Gabriela Venturini· 1 shared Gordana Vunjak-NovakoviciD· 1 shared Jaron Whitehead· 1 shared Jonathan G. SeidmaniD· 1 shared Laura Geraldino-Pardilla· 1 shared Manuel A. Tamargo· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Christine E. SeidmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury

Sharon Fleischer, Trevor R. Nash, Manuel A. Tamargo, Roberta I. Lock, Gabriela Venturini, Margaretha Morsink, Pamela L. Graney, Vanessa Li, Morgan J. Lamberti, Martin Liberman, Youngbin Kim, Daniel N. Tavakol, Richard Z. Zhuang, Jaron Whitehead, Richard A. Friedman, , Gordana Vunjak-Novakovic

This study uses engineered human cardiac tissues to show how SLE autoantibodies affect myocardial injury through distinct binding patterns and functional effects on cardiac cells.

bioRxiv · Mar 7, 2024Bioengineering